Characterization of CD34+ Cells from Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Using a t-Distributed Stochastic Neighbor Embedding (t-SNE) Protocol

Cathrin Nollmann,Wiebke Moskorz,Christian Wimmenauer,Paul S. Jäger,Ron P. Cadeddu,Jörg Timm,Thomas Heinzel,Rainer Haas

DOI: https://doi.org/10.3390/cancers16071320

2024-03-29

Cancers

Abstract:Using multi-color flow cytometry analysis, we studied the immunophenotypical differences between leukemic cells from patients with AML/MDS and hematopoietic stem and progenitor cells (HSPCs) from patients in complete remission (CR) following their successful treatment. The panel of markers included CD34, CD38, CD45RA, CD123 as representatives for a hierarchical hematopoietic stem and progenitor cell (HSPC) classification as well as programmed death ligand 1 (PD-L1). Rather than restricting the evaluation on a 2- or 3-dimensional analysis, we applied a t-distributed stochastic neighbor embedding (t-SNE) approach to obtain deeper insight and segregation between leukemic cells and normal HPSCs. For that purpose, we created a t-SNE map, which resulted in the visualization of 27 cell clusters based on their similarity concerning the composition and intensity of antigen expression. Two of these clusters were "leukemia-related" containing a great proportion of CD34+/CD38− hematopoietic stem cells (HSCs) or CD34+ cells with a strong co-expression of CD45RA/CD123, respectively. CD34+ cells within the latter cluster were also highly positive for PD-L1 reflecting their immunosuppressive capacity. Beyond this proof of principle study, the inclusion of additional markers will be helpful to refine the differentiation between normal HSPCs and leukemic cells, particularly in the context of minimal disease detection and antigen-targeted therapeutic interventions. Furthermore, we suggest a protocol for the assignment of new cell ensembles in quantitative terms, via a numerical value, the Pearson coefficient, based on a similarity comparison of the t-SNE pattern with a reference.

oncology

What problem does this paper attempt to address?

The paper attempts to address the problem of characterizing CD34+ cells in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) using the t-distributed stochastic neighbor embedding (t-SNE) method, and comparing them with hematopoietic stem and progenitor cells (HSPCs) in patients who have achieved complete remission (CR).

Specifically:
1. **Research Background**: AML and MDS are heterogeneous diseases caused by genetic and epigenetic changes in hematopoietic stem cells (HSCs), leading to clonal expansion of myeloid precursor cells in the bone marrow and peripheral blood, accompanied by impaired cell differentiation.
2. **Main Objective**: To better understand the immunophenotypic characteristics of these diseases, researchers analyzed CD34+ cells from AML/MDS patients using multicolor flow cytometry and compared them with HSPCs from patients who achieved complete remission after anti-tumor treatment.
3. **Technical Approach**: The t-SNE algorithm was used to perform dimensionality reduction on multidimensional data, thereby visualizing differences between different cell clusters in a two-dimensional space. This method can reveal complex structures and rare subpopulations that traditional two-dimensional scatter plots cannot display.
4. **Specific Application**: By comparing samples from AML/MDS patients and CR patients, the study identified certain specific cell clusters, two of which were considered "leukemia-related," containing a large number of CD34+/CD38− hematopoietic stem cells or CD34+ cells. These cells highly expressed CD45RA/CD123 and PD-L1, showing immunosuppressive capabilities.

In summary, the paper aims to provide a detailed characterization of CD34+ cells in AML and MDS patients using the t-SNE method, in order to better understand the cellular subpopulation characteristics of these diseases and provide new insights for subsequent diagnosis and treatment.